MARLBOROUGH, Mass.,
Feb. 15, 2017 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) is scheduled to
participate in the 2017 RBC Capital Markets Global Healthcare
Conference on Thursday, February 23,
2017 in New York.
Dan Brennan, executive vice
president and chief financial officer, and Susie Lisa, vice president, Investor Relations,
will participate in a 30-minute question-and-answer-session with
the host analyst beginning at approximately 8:00 a.m.
A live webcast of the question-and-answer-session will be
available on the Investor Relations section of the Boston
Scientific website at www.bostonscientific.com/investors. We
encourage interested parties to register at least 15 minutes prior
to the scheduled start time to ensure a timely connection.
A replay of the webcast will be accessible at
www.bostonscientific.com/investors beginning approximately one hour
following the completion of the event.
About Boston Scientific
Boston Scientific
transforms lives through innovative medical solutions that improve
the health of patients around the world. As a global medical
technology leader for more than 35 years, we advance science for
life by providing a broad range of high performance solutions that
address unmet patient needs and reduce the cost of
healthcare. For more information, visit
www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Tom
Keppeler
|
Susie Lisa,
CFA
|
508-683-6585
(office)
|
508- 683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
thomas.keppeler@bsci.com
|
investor_relations@bsci.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-2017-rbc-capital-markets-global-healthcare-conference-300407622.html
SOURCE Boston Scientific Corporation